BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 10547590)

  • 21. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases involvement in pathologic conditions.
    Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
    Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K
    Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
    Okada Y
    Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
    O-Charoenrat P; Rhys-Evans PH; Eccles SA
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.
    Stetler-Stevenson WG
    Surg Oncol Clin N Am; 2001 Apr; 10(2):383-92, x. PubMed ID: 11382593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor metastasis and MMP inhibitor].
    Sato H
    Clin Calcium; 2006 Apr; 16(4):621- 26. PubMed ID: 16582513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
    Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.
    Curran S; Murray GI
    Eur J Cancer; 2000 Aug; 36(13 Spec No):1621-30. PubMed ID: 10959048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.